# Increased risk of arterial thromboembolic events with combination lenalidomide/dexamethasone therapy for multiple myeloma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/increased-risk-of-arterial-thromboembolic-events-with-combination-lenalidomide/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Satish Maharaj,Simone Chang,Karan Seegobin,Ivan Serrano-Santiago,Lara Zuberi |
| Citations | 12 |
| DOI | 10.1080/14737140.2017.1330153 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2614345038 |
| PMID | 28508703 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Satish Maharaj](https://scholariq.org/researchers/satish-maharaj/)

## Paper primary topic

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Paper topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.